| 摘要 |
Disclosed herein are methods of treating neurodegenerative diseases comprising administering to the subject a compound having the structure: ( l ) wherein a and R1-R8 are described herein, or a compound having the structure: ( ll ) wherein Y, Z, and R21, R24 / R25, and R31 -R33 are described herein. |
